Search

everythinglearnresearchcommunity

for

Search:↓

Hair fibers break by cuticle cell slipping, shape changing, cuticle fraying, and surface cracking when stretched under specific conditions.

Larger spheroids improve hair growth, but size doesn't guarantee thicker hair.

Finasteride effectively reduces hair loss by decreasing androgen levels.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Micrografts improve hair density and thickness without side effects.

A drug improved schizophrenia-like symptoms in stressed rats by changing brain steroid levels.

Patients with schizophrenia have a high rate of skin diseases, with fungal infections and dermatitis being most common, and those on clozapine have a lower risk of fungal infections.

Botulinum toxin's effectiveness for treating scalp alopecia is not well-supported due to insufficient data.

Turning scar-forming cells into fat cells can reduce scarring.

The research found that postmortem root bands in hair are likely caused by the breakdown of a specific part of the hair's inner structure after death.

The VSCAPSI is a helpful method for evaluating the severity of scalp psoriasis.

Effective scalp reconstruction requires a wide range of surgical skills and an understanding of hair biology.

The document concludes that scalp disorders can be treated with hair washing, specific shampoos, medications, and sometimes surgery or hair transplants, but hereditary baldness is untreatable.

Using tacalcitol ointment with photodynamic therapy may effectively treat follicular mucinosis with scalp hair loss.

A certain medication improved severe itching in a boy with liver and bowel disease by reducing histamine levels, suggesting a new treatment target.

The hair follicle's connective tissue is a key source of a certain collagen in human scalp skin.

The anti-viral drug Elvitegravir may protect brain cells from damage related to neurodegenerative diseases.

The document suggests that severe hair loss in SLE patients may be an early sign of scalp DLE, treatable with immunosuppressive therapy.

Many people diagnosed with androgenic alopecia might actually have hidden scarring or inflammation.

The study created a new method to test drugs that affect hormone processing in skin.

Hair transplant surgery reduces scalp sensitivity by almost 40%, and smokers have less scalp sensitivity than non-smokers. The time since surgery doesn't significantly affect this.

The document concludes that using a phototrichogram with a protractor and tapeline is a reliable and noninvasive way to measure hair loss.

Double trichophytic closure effectively treats thin scalp scars and reduces patient costs.

The document concludes that dermatology training and grading scales need to better represent dark-skinned individuals to improve diagnosis and assessment of skin conditions.

The document concludes that while some hair and scalp disorders can be treated, hair loss from destroyed follicles is permanent, and damaged hair can only regrow naturally.

Gender affects hair and scalp characteristics, with differences in hormone responses, graying patterns, and trace metals.

Intramuscular injections improved hair density more than intradermal injections for treating hair loss.

Patients with Systemic Sclerosis have much higher levels of GDF-15, which could help predict organ involvement and guide treatment.

Scarred skin in lichen planopilaris loses immune cells due to a decrease in a specific protein in skin cells.

Patients with lichen planus should be tested for hepatitis C.